rs2075827

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000565221.5(PMM2):​n.*495A>C variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.265 in 668,580 control chromosomes in the GnomAD database, including 24,247 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.25 ( 4994 hom., cov: 33)
Exomes 𝑓: 0.27 ( 19253 hom. )

Consequence

PMM2
ENST00000565221.5 non_coding_transcript_exon

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.0670

Publications

14 publications found
Variant links:
Genes affected
PMM2 (HGNC:9115): (phosphomannomutase 2) The protein encoded by this gene catalyzes the isomerization of mannose 6-phosphate to mannose 1-phosphate, which is a precursor to GDP-mannose necessary for the synthesis of dolichol-P-oligosaccharides. Mutations in this gene have been shown to cause defects in glycoprotein biosynthesis, which manifests as carbohydrate-deficient glycoprotein syndrome type I. [provided by RefSeq, Jul 2008]
PMM2 Gene-Disease associations (from GenCC):
  • congenital disorder of glycosylation type I
    Inheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health
  • PMM2-congenital disorder of glycosylation
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet, PanelApp Australia, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 16-8847961-A-C is Benign according to our data. Variant chr16-8847961-A-C is described in ClinVar as Benign. ClinVar VariationId is 321229.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.326 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PMM2NM_000303.3 linkc.*136A>C 3_prime_UTR_variant Exon 8 of 8 ENST00000268261.9 NP_000294.1 O15305-1A0A0S2Z4J6Q59F02
PMM2XM_047434215.1 linkc.*136A>C 3_prime_UTR_variant Exon 6 of 6 XP_047290171.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PMM2ENST00000268261.9 linkc.*136A>C 3_prime_UTR_variant Exon 8 of 8 1 NM_000303.3 ENSP00000268261.4 O15305-1

Frequencies

GnomAD3 genomes
AF:
0.253
AC:
38450
AN:
152032
Hom.:
4994
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.221
Gnomad AMI
AF:
0.245
Gnomad AMR
AF:
0.214
Gnomad ASJ
AF:
0.223
Gnomad EAS
AF:
0.321
Gnomad SAS
AF:
0.340
Gnomad FIN
AF:
0.298
Gnomad MID
AF:
0.177
Gnomad NFE
AF:
0.265
Gnomad OTH
AF:
0.245
GnomAD4 exome
AF:
0.268
AC:
138660
AN:
516430
Hom.:
19253
Cov.:
6
AF XY:
0.273
AC XY:
75198
AN XY:
275032
show subpopulations
African (AFR)
AF:
0.222
AC:
3327
AN:
14984
American (AMR)
AF:
0.185
AC:
5683
AN:
30770
Ashkenazi Jewish (ASJ)
AF:
0.220
AC:
3723
AN:
16924
East Asian (EAS)
AF:
0.310
AC:
9735
AN:
31406
South Asian (SAS)
AF:
0.337
AC:
18986
AN:
56282
European-Finnish (FIN)
AF:
0.284
AC:
9162
AN:
32264
Middle Eastern (MID)
AF:
0.237
AC:
541
AN:
2282
European-Non Finnish (NFE)
AF:
0.264
AC:
80050
AN:
302828
Other (OTH)
AF:
0.260
AC:
7453
AN:
28690
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
4975
9949
14924
19898
24873
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
576
1152
1728
2304
2880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.253
AC:
38456
AN:
152150
Hom.:
4994
Cov.:
33
AF XY:
0.256
AC XY:
19070
AN XY:
74392
show subpopulations
African (AFR)
AF:
0.220
AC:
9135
AN:
41508
American (AMR)
AF:
0.214
AC:
3269
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.223
AC:
774
AN:
3468
East Asian (EAS)
AF:
0.320
AC:
1658
AN:
5174
South Asian (SAS)
AF:
0.340
AC:
1639
AN:
4822
European-Finnish (FIN)
AF:
0.298
AC:
3163
AN:
10598
Middle Eastern (MID)
AF:
0.184
AC:
54
AN:
294
European-Non Finnish (NFE)
AF:
0.265
AC:
18018
AN:
67976
Other (OTH)
AF:
0.247
AC:
523
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1478
2955
4433
5910
7388
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
412
824
1236
1648
2060
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.258
Hom.:
21613
Bravo
AF:
0.240

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

PMM2-congenital disorder of glycosylation Benign:2
Jul 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:2
Jun 29, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
1.4
DANN
Benign
0.53
PhyloP100
-0.067
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2075827; hg19: chr16-8941818; API